Shenzhen New Industries Biomedical Engineering Co (SZSE:300832) Change In Receivables : ¥0 Mil (TTM As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Shenzhen New Industries Biomedical Engineering Co Change In Receivables?

Shenzhen New Industries Biomedical Engineering Co's change in receivables for the quarter that ended in Mar. 2024 was ¥0 Mil. It means Shenzhen New Industries Biomedical Engineering Co's Accounts Receivable stayed the same from Dec. 2023 to Mar. 2024 .

Shenzhen New Industries Biomedical Engineering Co's change in receivables for the fiscal year that ended in Dec. 2023 was ¥-277 Mil. It means Shenzhen New Industries Biomedical Engineering Co's Accounts Receivable increased by ¥277 Mil from Dec. 2022 to Dec. 2023 .

Shenzhen New Industries Biomedical Engineering Co's Accounts Receivable for the quarter that ended in Mar. 2024 was ¥723 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Shenzhen New Industries Biomedical Engineering Co's Days Sales Outstanding for the three months ended in Mar. 2024 was 64.62.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Shenzhen New Industries Biomedical Engineering Co's liquidation value for the three months ended in Mar. 2024 was ¥3,711 Mil.

Shenzhen New Industries Biomedical Engineering Co Change In Receivables Historical Data

The historical data trend for Shenzhen New Industries Biomedical Engineering Co's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shenzhen New Industries Biomedical Engineering Co Change In Receivables Chart

Shenzhen New Industries Biomedical Engineering Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

-34.14

-60.45

-154.66

-240.16

-277.18

Shenzhen New Industries Biomedical Engineering Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-	-

Shenzhen New Industries Biomedical Engineering Co Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.

Shenzhen New Industries Biomedical Engineering Co (SZSE:300832) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Shenzhen New Industries Biomedical Engineering Co's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	723.383	/	1021.43	*	91
=	64.62

2. In Ben Graham's calculation of liquidation value, Shenzhen New Industries Biomedical Engineering Co's accounts receivable are only considered to be worth 75% of book value:

Shenzhen New Industries Biomedical Engineering Co's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	3302.179	-	610.451	+	0.75 * 723.383	+	0.5 * 953.209
=	3,711

Shenzhen New Industries Biomedical Engineering Co Change In Receivables Related Terms

Thank you for viewing the detailed overview of Shenzhen New Industries Biomedical Engineering Co's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Shenzhen New Industries Biomedical Engineering Co (SZSE:300832) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shenzhen New Industries Biomedical Engineering Co Ltd (SZSE:300832) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 23, Jinxiu East Road, Kengzi Street, 21st Floor, New Industrial Bio Building, Jinsha Community, Pingshan District, Guangdong Province, Shenzhen, CHN, 518000

Website

http://www.snibe.com

Shenzhen New Industries Biomedical Engineering Co Ltd is a bio-medical company specialized in clinical laboratory instruments and in vitro diagnostic reagents. The company produces and sells series of automatic chemiluminescence immunoassay instruments and supporting reagents. Its products include Immunoassay, Clinical Chemistry, Integrated System, Lab Automation, and Reagents.

Executives

Ma Jie	Supervisors
Ding Chen Liu	Executives
Zhang Xiao Hong	Executives
Zhang Lei	Directors, executives
Li Ting Hua	Executives
Liu Hai Yan	Executives
Song Hong Tao	Supervisors
Liu Peng	Director
Jiang Li Li	Supervisors

Shenzhen New Industries Biomedical Engineering Co (SZSE:300832) Headlines

No Headlines